241 related articles for article (PubMed ID: 36293543)
1. Fatty Acid Amide Hydrolase Deficiency Is Associated with Deleterious Cardiac Effects after Myocardial Ischemia and Reperfusion in Mice.
Rajlic S; Surmann L; Zimmermann P; Weisheit CK; Bindila L; Treede H; Velten M; Daiber A; Duerr GD
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293543
[TBL] [Abstract][Full Text] [Related]
2. Cardiomyocyte specific peroxisome proliferator-activated receptor-α overexpression leads to irreversible damage in ischemic murine heart.
Duerr GD; Heinemann JC; Arnoldi V; Feisst A; Kley J; Ghanem A; Welz A; Dewald O
Life Sci; 2014 May; 102(2):88-97. PubMed ID: 24657893
[TBL] [Abstract][Full Text] [Related]
3. The endocannabinoid-CB2 receptor axis protects the ischemic heart at the early stage of cardiomyopathy.
Duerr GD; Heinemann JC; Suchan G; Kolobara E; Wenzel D; Geisen C; Matthey M; Passe-Tietjen K; Mahmud W; Ghanem A; Tiemann K; Alferink J; Burgdorf S; Buchalla R; Zimmer A; Lutz B; Welz A; Fleischmann BK; Dewald O
Basic Res Cardiol; 2014 Jul; 109(4):425. PubMed ID: 24980781
[TBL] [Abstract][Full Text] [Related]
4. Decreased age-related cardiac dysfunction, myocardial nitrative stress, inflammatory gene expression, and apoptosis in mice lacking fatty acid amide hydrolase.
Bátkai S; Rajesh M; Mukhopadhyay P; Haskó G; Liaudet L; Cravatt BF; Csiszár A; Ungvári Z; Pacher P
Am J Physiol Heart Circ Physiol; 2007 Aug; 293(2):H909-18. PubMed ID: 17434980
[TBL] [Abstract][Full Text] [Related]
5. Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment.
Guindon J; Lai Y; Takacs SM; Bradshaw HB; Hohmann AG
Pharmacol Res; 2013 Jan; 67(1):94-109. PubMed ID: 23127915
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of fatty acid amide hydrolase and cyclooxygenase-2 increases levels of endocannabinoid related molecules and produces analgesia via peroxisome proliferator-activated receptor-alpha in a model of inflammatory pain.
Jhaveri MD; Richardson D; Robinson I; Garle MJ; Patel A; Sun Y; Sagar DR; Bennett AJ; Alexander SP; Kendall DA; Barrett DA; Chapman V
Neuropharmacology; 2008 Jul; 55(1):85-93. PubMed ID: 18534634
[TBL] [Abstract][Full Text] [Related]
7. The fatty acid amide hydrolase (FAAH) inhibitor PF-3845 acts in the nervous system to reverse LPS-induced tactile allodynia in mice.
Booker L; Kinsey SG; Abdullah RA; Blankman JL; Long JZ; Ezzili C; Boger DL; Cravatt BF; Lichtman AH
Br J Pharmacol; 2012 Apr; 165(8):2485-96. PubMed ID: 21506952
[TBL] [Abstract][Full Text] [Related]
8. Involvement of the endocannabinoid system in the physiological response to transient common carotid artery occlusion and reperfusion.
Quartu M; Poddighe L; Melis T; Serra MP; Boi M; Lisai S; Carta G; Murru E; Muredda L; Collu M; Banni S
Lipids Health Dis; 2017 Jan; 16(1):14. PubMed ID: 28103941
[TBL] [Abstract][Full Text] [Related]
9. Role for fatty acid amide hydrolase (FAAH) in the leptin-mediated effects on feeding and energy balance.
Balsevich G; Sticht M; Bowles NP; Singh A; Lee TTY; Li Z; Chelikani PK; Lee FS; Borgland SL; Hillard CJ; McEwen BS; Hill MN
Proc Natl Acad Sci U S A; 2018 Jul; 115(29):7605-7610. PubMed ID: 29967158
[TBL] [Abstract][Full Text] [Related]
10. Involvement of the endocannabinoid system in retinal damage after high intraocular pressure-induced ischemia in rats.
Nucci C; Gasperi V; Tartaglione R; Cerulli A; Terrinoni A; Bari M; De Simone C; Agrò AF; Morrone LA; Corasaniti MT; Bagetta G; Maccarrone M
Invest Ophthalmol Vis Sci; 2007 Jul; 48(7):2997-3004. PubMed ID: 17591864
[TBL] [Abstract][Full Text] [Related]
11. β-Amyloid exacerbates inflammation in astrocytes lacking fatty acid amide hydrolase through a mechanism involving PPAR-α, PPAR-γ and TRPV1, but not CB₁ or CB₂ receptors.
Benito C; Tolón RM; Castillo AI; Ruiz-Valdepeñas L; Martínez-Orgado JA; Fernández-Sánchez FJ; Vázquez C; Cravatt BF; Romero J
Br J Pharmacol; 2012 Jun; 166(4):1474-89. PubMed ID: 22321194
[TBL] [Abstract][Full Text] [Related]
12. Targeting fatty acid amide hydrolase (FAAH) to treat pain and inflammation.
Schlosburg JE; Kinsey SG; Lichtman AH
AAPS J; 2009 Mar; 11(1):39-44. PubMed ID: 19184452
[TBL] [Abstract][Full Text] [Related]
13. Involvement of fatty acid amide hydrolase and fatty acid binding protein 5 in the uptake of anandamide by cell lines with different levels of fatty acid amide hydrolase expression: a pharmacological study.
Björklund E; Blomqvist A; Hedlin J; Persson E; Fowler CJ
PLoS One; 2014; 9(7):e103479. PubMed ID: 25078278
[TBL] [Abstract][Full Text] [Related]
14. The novel reversible fatty acid amide hydrolase inhibitor ST4070 increases endocannabinoid brain levels and counteracts neuropathic pain in different animal models.
Caprioli A; Coccurello R; Rapino C; Di Serio S; Di Tommaso M; Vertechy M; Vacca V; Battista N; Pavone F; Maccarrone M; Borsini F
J Pharmacol Exp Ther; 2012 Jul; 342(1):188-95. PubMed ID: 22514334
[TBL] [Abstract][Full Text] [Related]
15. Cannabinoid CB1 receptors regulate salivation.
Andreis K; Billingsley J; Naimi Shirazi K; Wager-Miller J; Johnson C; Bradshaw H; Straiker A
Sci Rep; 2022 Aug; 12(1):14182. PubMed ID: 35986066
[TBL] [Abstract][Full Text] [Related]
16. CpG postconditioning after reperfused myocardial infarction is associated with modulated inflammation, less apoptosis, and better left ventricular function.
Duerr GD; Wu S; Schneider ML; Marggraf V; Weisheit CK; Velten M; Verfuerth L; Frede S; Boehm O; Treede H; Dewald O; Baumgarten G; Kim SC
Am J Physiol Heart Circ Physiol; 2020 Nov; 319(5):H995-H1007. PubMed ID: 32857588
[TBL] [Abstract][Full Text] [Related]
17. Cannabinoid activation of PPAR alpha; a novel neuroprotective mechanism.
Sun Y; Alexander SP; Garle MJ; Gibson CL; Hewitt K; Murphy SP; Kendall DA; Bennett AJ
Br J Pharmacol; 2007 Nov; 152(5):734-43. PubMed ID: 17906680
[TBL] [Abstract][Full Text] [Related]
18. Hemodynamic profile, responsiveness to anandamide, and baroreflex sensitivity of mice lacking fatty acid amide hydrolase.
Pacher P; Bátkai S; Osei-Hyiaman D; Offertáler L; Liu J; Harvey-White J; Brassai A; Járai Z; Cravatt BF; Kunos G
Am J Physiol Heart Circ Physiol; 2005 Aug; 289(2):H533-41. PubMed ID: 15821037
[TBL] [Abstract][Full Text] [Related]
19. Effects of fatty acid amide hydrolase (FAAH) inhibitors on working memory in rats.
Panlilio LV; Thorndike EB; Nikas SP; Alapafuja SO; Bandiera T; Cravatt BF; Makriyannis A; Piomelli D; Goldberg SR; Justinova Z
Psychopharmacology (Berl); 2016 May; 233(10):1879-88. PubMed ID: 26558620
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of fatty acid amide hydrolase activates Nrf2 signalling and induces heme oxygenase 1 transcription in breast cancer cells.
Li H; Wood JT; Whitten KM; Vadivel SK; Seng S; Makriyannis A; Avraham HK
Br J Pharmacol; 2013 Oct; 170(3):489-505. PubMed ID: 23347118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
